Julie E Bauman

22PUBLICATIONS
130CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Other biomedical and clinical sciences not elsewhere classifiedLiquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 25, 2026
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

|Dec 04, 2025
Reply to: Noncomparative Comparisons: The Paradox of Randomized Noncomparative Trials.

Robert L Ferris, Julie E Bauman, Hong Wang

|Nov 23, 2025
Implementation of a Healthcare Implicit Bias Training across Three Oncology Care Settings.

Dana Rosenberg, Teletia Taylor, Hannah Arem

|May 27, 2025
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer.

Dan P Zandberg, Lazar Vujanovic, David A Clump

|Oct 18, 2024
Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma.

Aaron R Hansen, Carlos A Gomez-Roca, Debbie G J Robbrecht

|Aug 08, 2024
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.

Justin F Gainor, Manish R Patel, Jeffrey S Weber

Pageof 4

Frequent Collaborators

4 joint publications

Nabil F Saba

3 joint publications

Robert L Ferris

2 joint publications

Dan P Zandberg

2 joint publications

Brian Robert Isett